Prasterone
Who holds supplier records for Prasterone? 7 organisations hold a current record for Prasterone: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: China (4), Italy (1), United States (1) and India (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Prasterone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/prasterone
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Prasterone expires 19 Mar 2031. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Prasterone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP LTDChinaActive DMF 32361, 24438 · latest filing Dec 2017
- FIS FABBRICA ITALIANA SINTETICI SPAItaly Company GMP cert on recordActive DMF 27340 · latest filing Sept 2013
- HUBEI GOTO BIOPHARM CO LTDChinaActive DMF 30447 · latest filing Mar 2016
- HUBEI GOTO BIOTECHNOLOGY CO LTDChinaActive DMF 41647 · latest filing Mar 2025
- Pfizer Inc.United StatesActive DMF 28729 · latest filing Dec 2014
- SYMBIOTEC PHARMALAB PRIVATE LTDIndia Company GMP cert on recordActive DMF 29004 · latest filing Jan 2015
- Zhejiang Xianju Junye Pharmaceutical Co., Ltd.(Yangfu site)ChinaActive DMF 28254 · latest filing Apr 2014
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Prasterone are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- PRODUCTOS QUIMICOS NATURALES SA DE CV PROQUINAInactive DMF 24216 · filed Sept 2010
- DIOSYNTH BVInactive DMF 12614 · filed Aug 1997
- United States · Inactive DMF 10691 · filed Jan 1994
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Prasterone). The latest listed patent expires 19 Mar 2031. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Prasterone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL90593).
Chemical identity
- IUPAC name
- (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
- Canonical SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C
- InChIKey
- FMGSKLZLMKYGDP-USOAJAOKSA-N
- Synonyms
- Androst-5-en-3.alpha.-ol-17-one, Biolaif, Dehydroandrosterone, Dehydroepiandrosterone, Dehydroisoandrosterone, Dhea, EM-760, Enzymatic therapy, Intrarosa, Isoandrostenolone, Natrol dhea, NSC-9896
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Prasterone?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Prasterone: JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP LTD (China), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), HUBEI GOTO BIOPHARM CO LTD (China), HUBEI GOTO BIOTECHNOLOGY CO LTD (China), Pfizer Inc. (United States), SYMBIOTEC PHARMALAB PRIVATE LTD (India) and Zhejiang Xianju Junye Pharmaceutical Co., Ltd.(Yangfu site) (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Prasterone Drug Master Files are active?
JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP LTD (DMF 32361, 24438), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 27340), HUBEI GOTO BIOPHARM CO LTD (DMF 30447), HUBEI GOTO BIOTECHNOLOGY CO LTD (DMF 41647), Pfizer Inc. (DMF 28729), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 29004) and Zhejiang Xianju Junye Pharmaceutical Co., Ltd.(Yangfu site) (DMF 28254). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Prasterone records mean?
3 organisations have only inactive Type II DMFs for Prasterone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Prasterone?
Yes. The latest patent listed for an approved US product containing Prasterone expires 19 Mar 2031, across 1 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Prasterone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Prasterone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.